Importantly, the combination of LIG1 and PARP inhibitors significantly reduced the survival of PCa and BRCA cells (synergy scores >10) (Figure 6, B, C, and E, and Supplemental Figure 6, B and C). This evidence concerns the gene PARP1 and posterior cortical atrophy.